Trop2 plays a cardioprotective role by promoting cardiac c-kit+ cell proliferation and inhibition of apoptosis in the acute phase of myocardial infarction

International Journal of Molecular Medicine

Volumn 31, Issue 6, 2013, Pages 1298-1304

  Yang, Jianye ^a   Zhou, Yuan ^b   Liu, Bo ^a   Wang, Hongfei ^a   Du, Xinling ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac c kit+ cells; Myocardial infarction; Proliferation; Trop2

Indexed keywords

CYTOKINE; GLYCOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TROP2; S6 KINASE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART PROTECTION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; BASE SEQUENCE; CELL ADHESION MOLECULES; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HEART; INFLAMMATION MEDIATORS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-KIT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84876388695     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1332     Document Type: Article

References (29)

1. Lipinski M, Parks DR, Rouse RV and Herzenberg LA: Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci USA 78: 5147-5150, 1981. (Pubitemid 12229690)
2. Kobayashi H, Minami Y, Anami Y, et al: Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Arch 457: 69-76, 2010.
3. Muhlmann G, Spizzo G, Gostner J, et al: TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 62: 152-158, 2009.
4. Wang J, Day R, Dong Y, Weintraub SJ and Michel L: Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 7: 280-285, 2008. (Pubitemid 351302522)
5. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12: 3057-3063, 2006. (Pubitemid 43837351)
6. Fong D, Moser P, Krammel C, et al: High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99: 1290-1295, 2008.
7. Bignotti E, Todeschini P, Calza S, et al: Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 46: 944-953, 2010.
8. Trerotola M, Rathore S, Goel HL, et al: CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2: 135-144, 2010.
9. Fong D, Spizzo G, Gostner JM, et al: TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21: 186-191, 2008. (Pubitemid 351172170)
10. Okabe M, Tsukahara Y, Tanaka M, et al: Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 136: 1951-1960, 2009.
11. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP and Witte ON: Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 105: 20882-20887, 2008.
12. Ripani E, Sacchetti A, Corda D and Alberti S: Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 76: 671-676, 1998. (Pubitemid 28243939)
13. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S and Izumo S: Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349-360, 2004. (Pubitemid 38420055)
14. Han Y, Chen JD, Liu ZM, et al: Functional ion channels in mouse cardiac c-kit(+) cells. Am J Physiol Cell Physiol 298: C1109-C1117 2010
15. Shimamura A, Ballif BA, Richards SA and Blenis J: Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 10: 127-135, 2000. (Pubitemid 30115743)
16. Roux PP, Richards SA and Blenis J: Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol Cell Biol 23: 4796-4804, 2003. (Pubitemid 36793327)
17. Alpert JS, Thygesen K, Antman E and Bassand JP: Myocardial infarction redefined -a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36: 959-969, 2000.
18. Berridge MJ, Lipp P and Bootman MD: The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21, 2000.
19. Petersen BE, Goff JP, Greenberger JS and Michalopoulos GK: Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 27: 433-445, 1998. (Pubitemid 28081058)
20. Anversa P, Kajstura J, Leri A and Bolli R: Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113: 1451-1463, 2006. (Pubitemid 43739442)
21. Urbanek K, Torella D, Sheikh F, et al: Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102: 8692-8697, 2005. (Pubitemid 40862797)
22. Urbanek K, Quaini F, Tasca G, et al: Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 100: 10440-10445, 2003. (Pubitemid 37071897)
23. Levonen AL, Vahakangas E, Koponen JK and Yla-Herttuala S: Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 117: 2142-2150, 2008. (Pubitemid 351572172)
24. Brinckmann M, Kaschina E, Altarche-Xifro W, et al: Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells. J Mol Cell Cardiol 47: 66-75, 2009.
25. Altarche-Xifro W, Curato C, Kaschina E, et al: Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells 27: 2488-2497, 2009.
26. Padin-Iruegas ME, Misao Y, Davis ME, et al: Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 120: 876-887, 2009.
27. Lavu M, Gundewar S and Lefer DJ: Gene therapy for ischemic heart disease. J Mol Cell Cardiol 50: 742-750, 2011.
28. Anjum R and Blenis J: The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9: 747-758, 2008.
29. Cubas R, Li M, Chen C and Yao Q: Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta 1796: 309-314, 2009.